Literature DB >> 309483

Identification and cytotoxic reactivity of inflammatory cells recovered from progressing or regressing syngeneic UV-induced murine tumors.

P H Lill, G W Fortner.   

Abstract

Most tumors induced in C3H mice by ultraviolet (UV) light are immunologically rejected by normal syngeneic recipients, but will grow progressively in immunosuppressed mice and in mice treated with UV light. In this study we compared the composition and cytotoxic activity of the inflammatory cell infiltrate from tumors transplanted into syngeneic UV-irradiated or unirradiated mice. Tumor fragments were implanted in either normal (regressor) or UV-treated (progressor) mice, and removed on various days after implantation and mechanically dissociated. The cells were examined by immunofluorescence for theta and immunoglobulin markers, stained for morphologic examination, and tested for cytotoxicity against the tumor. No significant differences were noted in numbers of macrophages, granulocytes, or B cells recovered from progressing or regressing tumors on day 6, the time of greatest activity. However, the numbers of T cells recovered from tumor fragments implanted in normal mice was approximately 3-fold that recovered from tumor fragments implanted in UV-treated mice. Lymphocytes recovered from regressing tumor fragments were specifically cytotoxic for that tumor in a microcytotoxicity test; those from progressing tumor fragments were not cytotoxic.

Entities:  

Mesh:

Year:  1978        PMID: 309483

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.

Authors:  Junya Nishimura; Hiroaki Tanaka; Yoshihito Yamakoshi; Soichiro Hiramatsu; Tatsuro Tamura; Takahiro Toyokawa; Kazuya Muguruma; Kiyoshi Maeda; Kosei Hirakawa; Masaichi Ohira
Journal:  Esophagus       Date:  2019-04-09       Impact factor: 4.230

Review 2.  Photoimmunology of experimental melanoma.

Authors:  C K Donawho; M L Kripke
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

3.  Characterization of variant and parental-cross-protective immunity to immunogenic variants of a murine fibrosarcoma using the local adoptive transfer assay.

Authors:  W Simcik; T L Sheu; S J LeGrue
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Histopathology and host response associated with reduced tumorigenicity of 5-bromodeoxyuridine--treated murine melanoma cells.

Authors:  K K Gyi; J R Wrathall
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

5.  Emergence of a dominant cytotoxic T lymphocyte antitumor effector from tumor-infiltrating cells in the anterior chamber of the eye.

Authors:  T L Knisely; J Y Niederkorn
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

6.  Selection of macrophage-resistant progressor tumor variants by the normal host. Requirement for concomitant T cell-mediated immunity.

Authors:  J L Urban; H Schreiber
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.